Mindfulness Based Cognitive Therapy for Bipolar Disorder
MBCT-BD
1 other identifier
interventional
144
1 country
4
Brief Summary
The current study will be a randomized controlled trial (RCT) investigating the clinical and cost-effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) as an adjunct to usual care, versus usual care alone, in reducing depressive symptoms in patients with bipolar disorder. Outcome measures include depressive, (hypo)manic and anxiety symptoms, risk of relapse/recurrence, functioning and mental health/well-being. The study also aims to explore possible working mechanisms such as improvements of mindfulness and self-compassion skills. The study will have a follow-up duration of 15 months from baseline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2017
CompletedStudy Start
First participant enrolled
April 23, 2018
CompletedFirst Posted
Study publicly available on registry
April 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2021
CompletedApril 18, 2023
April 1, 2023
2.2 years
September 18, 2017
April 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inventory of Depressive Symptomatology
A clinican-administered interview assessing the severity of depressive symptoms
Change between baseline and 3 months
Secondary Outcomes (19)
Structured Clinical Interview for DSM-IV-TR Disorders
Change between baseline and 15 months
Young Mania Rating Scale
Change between baseline and 3 months
Young Mania Rating Scale
Change between baseline and 15 months
Functioning Assessment Short Test
Change between baseline and 3 months
Functioning Assessment Short Test
Change between baseline and 15 months
- +14 more secondary outcomes
Other Outcomes (12)
Euro-Quality of Life 5D-5L
baseline
Euro-Quality of Life 5D-5L
3 months
Euro-Quality of Life 5D-5L
6 months
- +9 more other outcomes
Study Arms (2)
Mindfulness Based Cognitive Therapy added to usual care
EXPERIMENTALPatients in the MBCT arm will be invited to participate in MBCT added to their usual care.
Usual Care
ACTIVE COMPARATORUsual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse).
Interventions
MBCT is a manualised group skills-training program (Segal, Williams \& Teasdale 2012) consisting of eight weekly sessions of 2.5 hours, plus one day of silent practice. The program includes both formal and informal meditation exercises. Cognitive techniques that are part of the program are education, monitoring and scheduling of activities, identification of negative automatic thoughts and devising a relapse prevention plan. The MBCT treatment will be adapted to address the needs of patients with a bipolar disorder. A few examples of these adaptations are: (more) psychoeducation about manic symptoms in addition to the psychoeduction about depression; introducing the 3-minute breathing space earlier in the programme and more often during sessions, especially when strong emotions are present; repeatedly bringing the focus to self-care; and making use of the mindful movement (yoga) exercises more frequently.
Usual care will typically consist of pharmacotherapy, psycho-education and self-management interventions (usually with a psychiatric nurse). Usual care will not be restricted, except for proscribing high-frequency psychological interventions such as (group) cognitive behavioral therapy, for practical and methodological reasons.
Eligibility Criteria
You may qualify if:
- bipolar I or II disorder
- having suffered at least two lifetime depressive episodes, either current or in (partial) remission at baseline (according to SCID assessment)
- Young Mania Rating Scale score \< 8
You may not qualify if:
- a manic episode in the 3 months before the start of the trial
- lifetime diagnosis of schizophrenia or schizoaffective disorder, current substance abuse disorder, organic brain syndrome, antisocial or borderline personality disorder
- risk of suicide or aggression
- the presence of a concurrent significant medical condition impeding the ability to participate
- currently receiving regular psychological therapy
- previous participation in a MBCT or MBSR course
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Radboud University Medical Centerlead
- ZonMw: The Netherlands Organisation for Health Research and Developmentcollaborator
- Pro Persona Mental Health Care Foundationcollaborator
- Altrechtcollaborator
- Dimencecollaborator
- PsyQcollaborator
Study Sites (4)
Radboud University Nijmegen Medical Center
Nijmegen, Gelderland, 6525 GC, Netherlands
Dimence GGZ
Deventer, Netherlands
Pro Persona
Nijmegen, Netherlands
Altrecht GGZ
Utrecht, Netherlands
Related Publications (4)
Hanssen I, Huijbers M, Regeer E, Lochmann van Bennekom M, Stevens A, van Dijk P, Boere E, Havermans R, Hoenders R, Kupka R, Speckens AE. Mindfulness-based cognitive therapy v. treatment as usual in people with bipolar disorder: A multicentre, randomised controlled trial. Psychol Med. 2023 Oct;53(14):6678-6690. doi: 10.1017/S0033291723000090. Epub 2023 Mar 7.
PMID: 39625263DERIVEDHanssen I, Scheepbouwer V, Huijbers M, Regeer E, Lochmann van Bennekom M, Kupka R, Speckens A. Adverse or therapeutic? A mixed-methods study investigating adverse effects of Mindfulness-Based Cognitive Therapy in bipolar disorder. PLoS One. 2021 Nov 4;16(11):e0259167. doi: 10.1371/journal.pone.0259167. eCollection 2021.
PMID: 34735517DERIVEDHanssen I, van der Horst N, Boele M, Lochmann van Bennekom M, Regeer E, Speckens A. The feasibility of mindfulness-based cognitive therapy for people with bipolar disorder: a qualitative study. Int J Bipolar Disord. 2020 Nov 11;8(1):33. doi: 10.1186/s40345-020-00197-y.
PMID: 33175338DERIVEDHanssen I, Huijbers MJ, Lochmann-van Bennekom MWH, Regeer EJ, Stevens AWMM, Evers SMAA, Wensing M, Kupka RW, Speckens AEM. Study protocol of a multicenter randomized controlled trial of mindfulness-based cognitive therapy and treatment as usual in bipolar disorder. BMC Psychiatry. 2019 Apr 30;19(1):130. doi: 10.1186/s12888-019-2115-6.
PMID: 31039765DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Speckens, Prof.
Radboud University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes will be assessed by independent research assistants blind to condition. Participants will be instructed to avoid unblinding as much as possible.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. dr.
Study Record Dates
First Submitted
September 18, 2017
First Posted
April 25, 2018
Study Start
April 23, 2018
Primary Completion
June 16, 2020
Study Completion
June 17, 2021
Last Updated
April 18, 2023
Record last verified: 2023-04